Figure 1. Sample nerve conduction recordings from standard NCS (A) and the point-of-care device (B) from a 60-year-old female with type 2 diabetes and an image of the point-of-care procedure (C).

Panel A: Sample standard NCS recording. Sural nerve amplitude potential was 6.8 µV and conduction velocity was 48.3 m/s. Panel B: Sample recording from the point-of-care device. Sural nerve amplitude potential was 8 µV and conduction velocity was 56 m/s. Panel C: The device was placed on the lateral aspect of the leg and the sural nerve was stimulated and recorded by the electrical probes and biosensor, respectively.